Phase II study of preoperative bevacizumab, capecitabine and radiotherapy for resectable locally-advanced rectal cancer.
García M, Martinez-Villacampa M, Santos C, Navarro V, Teule A, Losa F, Pisa A, Cambray M, Soler G, Lema L, Kreisler E, Figueras A, Juan XS, Viñals F, Biondo S, Salazar R.
García M, et al.
BMC Cancer. 2015 Feb 26;15:59. doi: 10.1186/s12885-015-1052-0.
BMC Cancer. 2015.
PMID: 25886275
Free PMC article.
Clinical Trial.